Clinical Trials Logo
  1. Home
  2. Biomarkers
  3. NCT05881226
  4. Details
NCT05881226 Clinical Trial

Application of Biomarkers in Neurological Diseases

Biomarkers Clinical Trial

Official title:
Application of Biomarkers in Neurological Diseases

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05881226
Other study ID # Bio-Neuro
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 5, 2023
Est. completion date December 1, 2031

Study information
Verified date February 2024
Source The First Hospital of Jilin University
Contact Yi YY Yang, Ph.D.
Phone 18186872986
Email doctoryangyi@163.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To explore the predictive and diagnostic role of biomarkers in patients with neurological diseases.

Description:

With the rise and continuous development of omics technology and bioinformatics technology, some scholars have applied proteomics technology and metabolomics technology to study the brain tissue, plasma and CSF of patients with nervous system diseases, so as to screen out potential biomarkers, with a view to providing new research ideas for pathogenesis and early diagnosis of neurological diseases. At present, the research on some novel biomarkers is still in its infancy, and many key problems remain to be solved. It is necessary to further determine the expression level of biomarkers in normal human body and the characteristics of biomarkers in patients with neurological diseases.

Recruitment information / eligibility
Status Recruiting
Enrollment 3000
Est. completion date December 1, 2031
Est. primary completion date December 1, 2030
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. Patients with neurological diseases; 2. Subjects or legal agents agree to participate in the study and sign the informed consent. Exclusion Criteria: 1. Participating in other clinical investigators; 2. Unwilling to be followed up or poor treatment compliance; 3. Other conditions considered unsuitable for inclusion by the researchers.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China First Hospital of Jilin University Changchun Jilin

Sponsors (1)
Lead Sponsor Collaborator
Yi Yang

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary mRS score in 90 days The proportion of 3-month good functional outcome (mRS Score 0-2) in patients with neurological diseases was evaluated by mRS Score 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Recruiting NCT05548933 - Effects of Non-surgical Periodontal Therapy on Severe Periodontitis and Hyperlipidemia
Active, not recruiting NCT03926572 - Acute Decompensation of Pulmonary Hypertension N/A
Recruiting NCT05372159 - Vanderbilt Memory and Aging Project
Completed NCT03173586 - Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women N/A
Completed NCT04554628 - Early Prediction of Acute Kidney Injury Among Patients Admitted to Surgical ICU N/A
Terminated NCT03250312 - The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers N/A
Recruiting NCT04666766 - Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers N/A
Completed NCT04573543 - The Role of Immune Semaphorins in NAFLD
Completed NCT03193671 - Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis N/A
Recruiting NCT06047132 - PREDICTIVE ABILITY OF A PANEL OF BIOMARKERS IN SALIVA IN HEALTHY AND PERIODONTALLY AFFECTED SUBJECTS
Completed NCT05361460 - Patients Experiences of Early Postoperative Cognition
Recruiting NCT05706194 - Early Neuroprognostication After OHCA
Recruiting NCT05138731 - Metabolomics Profiling of Coronary Heart Disease
Not yet recruiting NCT04563000 - Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest Phase 2
Completed NCT05138692 - Biomarkers and Outcome 1 and 10-15 Years After Severe Traumatic Brain Injury
Completed NCT02247999 - Improving Cervical Cancer Screening Among HIV-Infected Women in India
Active, not recruiting NCT02732301 - Postoperative Gastrointestinal Dysfunction After Cardiac Surgery - Occurrence and Search for Biomarkers
Not yet recruiting NCT03269019 - Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia N/A
Recruiting NCT04062279 - Predictors of Parkinson's Disease Progression